In-vivo antithrombotic potency of placenta protein 4 (annexin V)

Thromb Res. 1991 Jan 15;61(2):93-104. doi: 10.1016/0049-3848(91)90236-p.

Abstract

The antithrombotic properties of Placenta Protein 4 (PP4) were investigated in laser or photochemically induced thrombus formation models in rats. In both in-vivo test-systems PP4 displayed a significant antithrombotic effect at dose levels as low as 0.3 and 1.0 mg/kg body weight. Bleeding times, surprisingly, were not prolonged significantly at these dose regimens. Maximal inhibition of thrombus formation in the laser-model was observed 15 min after intravenous administration of PP4, but was not recognizable in a clear-cut reaction in the second model. Determination of PP4 plasma levels in two monkeys revealed a half-life of 11.5 and 14.9 min, respectively. The maximal anticoagulant effect was observed between 15 and 30 min after administration of PP4 as determined functionally by means of thrombelastography.

MeSH terms

  • Animals
  • Annexin A5
  • Bleeding Time
  • Calcium-Binding Proteins / administration & dosage
  • Calcium-Binding Proteins / pharmacokinetics
  • Calcium-Binding Proteins / pharmacology*
  • Fibrinolytic Agents
  • Half-Life
  • Lasers
  • Macaca fascicularis
  • Male
  • Photochemistry
  • Pregnancy Proteins / administration & dosage
  • Pregnancy Proteins / pharmacokinetics
  • Pregnancy Proteins / pharmacology*
  • Rats
  • Thrombelastography
  • Thrombosis / blood
  • Thrombosis / etiology
  • Thrombosis / prevention & control*

Substances

  • Annexin A5
  • Calcium-Binding Proteins
  • Fibrinolytic Agents
  • Pregnancy Proteins